These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations. Napoli KL; Kahan BD J Chromatogr B Biomed Appl; 1994 Mar; 654(1):111-20. PubMed ID: 8004232 [TBL] [Abstract][Full Text] [Related]
5. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection. Napoli KL; Kahan BD Clin Chem; 1996 Dec; 42(12):1943-8. PubMed ID: 8969630 [TBL] [Abstract][Full Text] [Related]
6. Radioreceptor assay for sirolimus in patients with decreased platelet counts. Goodyear N; Napoli KL; Murthy JN; Kahan BD; Soldin SJ Clin Biochem; 1997 Oct; 30(7):539-43. PubMed ID: 9399022 [TBL] [Abstract][Full Text] [Related]
7. Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry. Streit F; Christians U; Schiebel HM; Napoli KL; Ernst L; Linck A; Kahan BD; Sewing KF Clin Chem; 1996 Sep; 42(9):1417-25. PubMed ID: 8787698 [TBL] [Abstract][Full Text] [Related]
8. Blood distribution of rapamycin. Yatscoff R; LeGatt D; Keenan R; Chackowsky P Transplantation; 1993 Nov; 56(5):1202-6. PubMed ID: 8249123 [TBL] [Abstract][Full Text] [Related]
9. Measurement of the active leflunomide metabolite (A77 1726) by reverse-phase high-performance liquid chromatography. Dias VC; Lucien J; LeGatt DF; Yatscoff RW Ther Drug Monit; 1995 Feb; 17(1):84-8. PubMed ID: 7725383 [TBL] [Abstract][Full Text] [Related]
10. Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standards: application to sirolimus (rapamycin) determination. Ferron GM; Conway WD; Jusko WJ J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):243-51. PubMed ID: 9448082 [TBL] [Abstract][Full Text] [Related]
11. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Fryer J; Yatscoff RW; Pascoe EA; Thliveris J Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385 [TBL] [Abstract][Full Text] [Related]
12. Automated simultaneous quantification of the immunosuppressants 40-O-(2-hydroxyethyl) rapamycin and cyclosporine in blood with electrospray-mass spectrometric detection. Vidal C; Kirchner GI; Wünsch G; Sewing KF Clin Chem; 1998 Jun; 44(6 Pt 1):1275-82. PubMed ID: 9625053 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the Abbott IMx sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet method. Johnson RN; Sargon R; Woollard G; Davidson J Ann Clin Biochem; 2005 Sep; 42(Pt 5):394-7. PubMed ID: 16168196 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations. Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of rapamycin: single-dose studies in the rabbit. Honcharik N; Fryer J; Yatscoff R Ther Drug Monit; 1992 Dec; 14(6):475-8. PubMed ID: 1485369 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of rapamycin: a new immunosuppressive drug. Yatscoff RW; LeGatt DF; Kneteman NM Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of sirolimus in kidney transplant patients. Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559 [TBL] [Abstract][Full Text] [Related]